bioXXmed Balance Sheet Health
Financial Health criteria checks 4/6
bioXXmed has a total shareholder equity of €21.1M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €21.3M and €230.3K respectively.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | n/a |
| Cash | €1.08m |
| Equity | €21.11m |
| Total liabilities | €230.34k |
| Total assets | €21.34m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: T5O's short term assets (€1.2M) exceed its short term liabilities (€212.8K).
Long Term Liabilities: T5O's short term assets (€1.2M) exceed its long term liabilities (€17.6K).
Debt to Equity History and Analysis
Debt Level: T5O is debt free.
Reducing Debt: T5O has no debt compared to 5 years ago when its debt to equity ratio was 25.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if T5O has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if T5O has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.